serine has been researched along with Cholangiocarcinoma in 10 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Cholangiocarcinoma: A malignant tumor arising from the epithelium of the BILE DUCTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence and mortality of intrahepatic cholangiocarcinoma (ICC) are increasing worldwide in recent decades." | 1.48 | Osteopontin promotes metastasis of intrahepatic cholangiocarcinoma through recruiting MAPK1 and mediating Ser675 phosphorylation of β-Catenin. ( Dong, QZ; Gao, XM; Jia, HL; Luo, Q; Qin, LX; Sheng, YY; Wang, CQ; Wei, JW; Wu, C; Yang, JM; Yu, XX; Zhang, Y; Zheng, Y; Zhou, C; Zhu, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Supradit, K | 1 |
| Boonsri, B | 1 |
| Duangdara, J | 1 |
| Thitiphatphuvanon, T | 1 |
| Suriyonplengsaeng, C | 1 |
| Kangsamaksin, T | 1 |
| Janvilisri, T | 1 |
| Tohtong, R | 1 |
| Yacqub-Usman, K | 2 |
| Grabowska, AM | 1 |
| Bates, DO | 2 |
| Wongprasert, K | 1 |
| Colyn, L | 1 |
| Alvarez-Sola, G | 1 |
| Latasa, MU | 1 |
| Uriarte, I | 1 |
| Herranz, JM | 1 |
| Arechederra, M | 1 |
| Vlachogiannis, G | 1 |
| Rae, C | 1 |
| Pineda-Lucena, A | 1 |
| Casadei-Gardini, A | 1 |
| Pedica, F | 1 |
| Aldrighetti, L | 1 |
| López-López, A | 1 |
| López-Gonzálvez, A | 1 |
| Barbas, C | 1 |
| Ciordia, S | 1 |
| Van Liempd, SM | 1 |
| Falcón-Pérez, JM | 1 |
| Urman, J | 1 |
| Sangro, B | 1 |
| Vicent, S | 1 |
| Iraburu, MJ | 1 |
| Prosper, F | 1 |
| Nelson, LJ | 1 |
| Banales, JM | 1 |
| Martinez-Chantar, ML | 1 |
| Marin, JJG | 1 |
| Braconi, C | 1 |
| Trautwein, C | 1 |
| Corrales, FJ | 1 |
| Cubero, FJ | 1 |
| Berasain, C | 1 |
| Fernandez-Barrena, MG | 1 |
| Avila, MA | 1 |
| Gao, CQ | 1 |
| Chu, ZZ | 1 |
| Zhang, D | 1 |
| Xiao, Y | 1 |
| Zhou, XY | 1 |
| Wu, JR | 1 |
| Yuan, H | 1 |
| Jiang, YC | 1 |
| Chen, D | 1 |
| Zhang, JC | 1 |
| Yao, N | 1 |
| Chen, KY | 1 |
| Hong, J | 1 |
| Wahid, M | 1 |
| Pratoomthai, B | 1 |
| Egbuniwe, IU | 1 |
| Evans, HR | 1 |
| Babaei-Jadidi, R | 1 |
| Amartey, JO | 1 |
| Erdelyi, V | 1 |
| Jackson, AM | 1 |
| Morris, JC | 1 |
| Patel, PM | 1 |
| Wunsch, E | 1 |
| Milkiewicz, P | 1 |
| Tornai, D | 1 |
| Papp, M | 1 |
| Zheng, Y | 1 |
| Zhou, C | 1 |
| Yu, XX | 1 |
| Wu, C | 1 |
| Jia, HL | 1 |
| Gao, XM | 1 |
| Yang, JM | 1 |
| Wang, CQ | 1 |
| Luo, Q | 1 |
| Zhu, Y | 1 |
| Zhang, Y | 1 |
| Wei, JW | 1 |
| Sheng, YY | 1 |
| Dong, QZ | 1 |
| Qin, LX | 1 |
| Xu, L | 1 |
| Wang, L | 1 |
| Zhou, L | 1 |
| Dorfman, RG | 1 |
| Pan, Y | 1 |
| Tang, D | 1 |
| Wang, Y | 1 |
| Yin, Y | 1 |
| Jiang, C | 1 |
| Zou, X | 1 |
| Wu, J | 1 |
| Zhang, M | 1 |
| Zeng, L | 1 |
| You, G | 1 |
| Tanaka, H | 1 |
| Srivatanakul, P | 1 |
| Ohta, E | 1 |
| Viwatthanasittiphong, C | 1 |
| Matharit, M | 1 |
| Chenvidhya, D | 1 |
| Jedpiyawongse, A | 1 |
| Tanaka, M | 1 |
| Fujii, T | 1 |
| Sripa, B | 1 |
| Ohshima, K | 1 |
| Miwa, M | 1 |
| Honjo, S | 1 |
| Vernez, M | 1 |
| Hutter, P | 1 |
| Monnerat, C | 1 |
| Halkic, N | 1 |
| Gugerli, O | 1 |
| Bouzourene, H | 1 |
10 other studies available for serine and Cholangiocarcinoma
| Article | Year |
|---|---|
Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis.
Topics: Arginine; Cholangiocarcinoma; Humans; Neovascularization, Pathologic; Protein Isoforms; Protein Seri | 2022 |
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.
Topics: Animals; Arachnodactyly; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinogenesis; Cholangiocar | 2022 |
Serine/threonine kinase TBK1 promotes cholangiocarcinoma progression via direct regulation of β-catenin.
Topics: Animals; beta Catenin; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocar | 2023 |
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T ce
Topics: Alternative Splicing; Arginine; B7-H1 Antigen; Cholangiocarcinoma; Humans; Immunotherapy; Interleuki | 2023 |
Editorial: serologic antibodies in primary sclerosing cholangitis-a tell-tale sign of compromised gut-liver immunity? Authors' reply.
Topics: Antibodies, Antineutrophil Cytoplasmic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarc | 2021 |
Editorial: serologic antibodies in primary sclerosing cholangitis - a tell-tale sign of compromised gut-liver immunity?
Topics: Antibodies, Antineutrophil Cytoplasmic; Cholangiocarcinoma; Cholangitis, Sclerosing; Gastrointestina | 2021 |
Osteopontin promotes metastasis of intrahepatic cholangiocarcinoma through recruiting MAPK1 and mediating Ser675 phosphorylation of β-Catenin.
Topics: Animals; beta Catenin; Bile Duct Neoplasms; Case-Control Studies; Cell Growth Processes; Cell Line, | 2018 |
The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
Topics: Animals; Apoptosis; Bile Duct Neoplasms; Cell Movement; Cell Proliferation; Cellular Reprogramming; | 2019 |
Combined effects of polymorphisms of DNA-repair protein genes and metabolic enzyme genes on the risk of cholangiocarcinoma.
Topics: Alanine; Arginine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cysteine; DNA | 2013 |
A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.
Topics: Adenocarcinoma, Mucinous; Adenoma; Adult; Brain Neoplasms; Carcinoma; Cholangiocarcinoma; Colorectal | 2007 |